Page 2 - Brain Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In a pioneering move, researchers at The Florey Institute have developed a novel method utilizing mRNA technology to directly target the tau protein, which plays a critical role in the development of Alzheimer's disease and other dementia-related conditions. This innovative approach marks the first time mRNA, widely recognized for its role in COVID-19 vaccines, has been applied to Alzheimer's disease, positioning The Florey as a leader in mRNA research.

Different parts of the brain may use different processes for preparing speech, according to a recent study by researchers from NYU’s Grossman School of Medicine. Researchers measured the time between stimulation of distinct areas of the brain and pauses in speech, and said that variations in the pauses indicated differences in speech preparation processes.  Over...

Get latest articles and stories on Science at LatestLY. Researchers at The Florey have created a method using mRNA technology to specifically target the harmful protein tau, which accumulates in dementia patients suffering from Alzheimer's disease and other conditions. Science News | Study Finds How MRNA Used to Target Alzheimer's Disease.

Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer's disease and other dementias.

Investigators found that mRNA technology for the delivery of antibody therapeutics were used to target tau in Alzheimer disease and can be applied to other tau targets.